'Epidemic of diagnosis' associated with thyroid cancer
2/21/2014
According to a new study published in JAMA Otolaryngology-Head & Neck Surgery, increased incidence of thyroid cancer may not be because of an increase in the disease, but an increase in diagnosis.Several types of cancer can affect the thyroid - a gland in the neck that produces hormones.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
Genetic screening could identify risk of advanced prostate cancer
2/21/2014
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring.
Gene test developed to accurately classify brain tumors
2/21/2014
Scientists at The Wistar Institute have developed a mathematical method for classifying forms of glioblastoma, an aggressive and deadly type of brain cancer, through variations in the way these tumor cells "read" genes. Their system was capable of predicting the subclasses of glioblastoma tumors with 92 percent accuracy.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
New leukemia immune cell therapy shows promise
2/20/2014
New findings on cell therapy to treat leukemia bring more encouraging news of the promise that this experimental area of cancer treatment holds for patients for whom conventional approaches do not work.
New leukemia immune cell therapy shows promise
2/20/2014
New findings on cell therapy to treat leukemia bring more encouraging news of the promise that this experimental area of cancer treatment holds for patients for whom conventional approaches do not work.
Data shows Prolaris test predicts metastases in prostate cancer from biopsies
2/20/2014
Myriad Genetics, Inc. has announced it has published data in the Journal of Urology demonstrating that its Prolaris test accurately predicted, based on biopsy specimens, which men would develop biochemical recurrence (BCR) or metastatic disease following radical prostate surgery.
A method for the diagnosis and prognosis of melanoma, the most aggressive skin cancer, is patented
2/20/2014
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate. This method will help not only in the more effective early detection of this cancer, but also in the development of more personalised treatments.
Data shows Prolaris test predicts metastases in prostate cancer from biopsies
2/20/2014
Myriad Genetics, Inc. has announced it has published data in the Journal of Urology demonstrating that its Prolaris test accurately predicted, based on biopsy specimens, which men would develop biochemical recurrence (BCR) or metastatic disease following radical prostate surgery.